Yvonne Kapila | Infections | Innovative Research Award

Innovative Research Award

Yvonne Kapila — University of California, Los Angeles, United States

Yvonne Kapila
Affiliation University of California, Los Angeles
Country United States
Scopus ID 6603814821
Documents 148
Citations 10,047
h-index 49
Subject Area Infections
Event Global Diseases Research Awards
ORCID 0000-0003-1330-0654

Yvonne Kapila is a researcher affiliated with the University of California, Los Angeles whose scholarly profile is associated with the field of infections. The available bibliographic profile records 148 documents, 10,047 citations, and an h-index of 49. These indicators provide a bibliometric overview of the researcher’s documented scholarly output and citation impact in indexed literature. [1]

Abstract

This article presents an academic recognition profile for Yvonne Kapila, affiliated with the University of California, Los Angeles, United States, in relation to the Innovative Research Award under the Global Diseases Research Awards. The profile summarizes available bibliometric indicators, including 148 documented publications or scholarly documents, 10,047 citations, and an h-index of 49, together with an identified subject area of infections. Bibliometric indicators are commonly used to describe patterns of scholarly productivity and citation influence, although they should be interpreted alongside qualitative evidence concerning research quality, relevance, originality, and contribution. [1]

Keywords

Yvonne Kapila; Innovative Research Award; University of California, Los Angeles; infections; infectious diseases; global diseases research; biomedical research; research impact; bibliometrics; Scopus; ORCID; scholarly publications.[1]

Introduction

Research in infectious diseases and related biomedical fields contributes to understanding disease mechanisms, prevention, diagnosis, treatment, and population-level health outcomes. Contemporary research assessment frequently combines bibliographic evidence with qualitative evaluation to provide a more complete understanding of scholarly contribution. Citation counts and h-index values can offer measurable indicators of scholarly visibility, while publication records provide information about the extent of documented research activity. [1]

Research Profile

The bibliographic information supplied for Yvonne Kapila identifies the University of California, Los Angeles as the institutional affiliation and the United States as the country of affiliation. The Scopus author identifier associated with the profile . The profile records 148 documents, 10,047 citations, and an h-index of 49. [2]

Research Contributions

The reported subject classification of infections places the research profile within a broad area encompassing infectious disease research and related biomedical investigation. Work in this domain can involve fundamental mechanisms, clinical research, translational science, diagnostic development, therapeutic strategies, prevention, and other approaches relevant to understanding infectious conditions. [1]

Publications

The supplied Scopus profile reports 148 documents associated with the researcher. These records represent the indexed publication output available through the cited author profile at the time of the supplied bibliometric assessment.Because individual publication titles, journal names, publication years, authorship positions, and DOI identifiers were not provided in the input data, this article does not assign specific publication-level claims to the researcher without additional bibliographic verification.[2]

Research Impact

The supplied bibliometric indicators indicate measurable scholarly visibility within indexed literature. A total of 10,047 citations and an h-index of 49 provide quantitative indicators of citation activity and sustained citation performance across the documented research record. [3]

Award Suitability

The supplied profile is presented in connection with the Innovative Research Award of the Global Diseases Research Awards. The reported research subject area of infections provides a thematic relationship with an award program focused on global disease research. The documented publication and citation indicators may also provide quantitative evidence of sustained scholarly activity. [4]

Conclusion

Yvonne Kapila’s supplied academic profile reflects a substantial indexed research record associated with the University of California, Los Angeles and the subject area of infections. The reported indicators of 148 documents, 10,047 citations, and an h-index of 49 provide a quantitative description of the researcher’s documented scholarly visibility. [5]

References

  1. Elsevier. (n.d.). Scopus author details: Yvonne Kapila, Author ID 6603814821. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=6603814821
  2. Global Diseases Research Awards. (n.d.). Global Diseases Research Awards.
    https://globaldiseases.org/
  3. Radaic, A., Malone, E., Lin, S., Curcino Araujo, L. D., Tse, I., Ganther, S., Kamarajan, P., Fenno, J. C., & Hernandez-Kapila, Y. L. (2026). Nisin-loaded solid lipid nanoparticles (SLN-Nisin) mitigate Treponema denticola intracellular infection and restore highly dysregulated host gene expression. Pharmaceuticals, 19(10), 1585.
    https://doi.org/10.3390/ph19101585

  4. ORCID. (n.d.). Yvonne Kapila — ORCID record.
    https://orcid.org/0000-0003-1330-0654
  5. Harutyunyan, L., & Hernandez-Kapila, Y. L. (2026). Dental implant survival, success, and failure in older populations: Beyond chronological age to systemic and local risk profiles. Periodontology 2000. https://doi.org/10.1111/prd.70077

Raeesa Manjoo-Docrat | Infectious Diseases | Young Researcher Award

Dr. Raeesa Manjoo-Docrat | Infectious Diseases | Young Researcher Award 

Lecturer | Univeristy of the Witwatersrand | South Africa

Dr. Raeesa Manjoo-Docrat is a developing scholar affiliated with the University of the Witwatersrand, Johannesburg, whose work contributes to the advancement of quantitative epidemiology and public health modelling in South Africa. Her research focuses on the development and application of spatial, age-stratified epidemiological models aimed at understanding disease transmission dynamics within heterogeneous populations. With four peer-reviewed publications and 27 citations, she has established a growing academic footprint supported by an h-index of 2, reflecting the early but significant influence of her work. Her recent open-access article in Heliyon (2025), which applies spatial modelling frameworks to the South African COVID-19 pandemic, exemplifies her commitment to integrating mathematical rigor with real-world public health challenges. Manjoo-Docrat has collaborated with multidisciplinary teams comprising epidemiologists, mathematicians, and public health scientists, enabling her to contribute to robust analytical frameworks and high-quality scientific outputs. These collaborations also highlight her ability to operate effectively within diverse research environments and to engage in evidence-based problem solving that supports both academic and policy-relevant outcomes. Her research sits at the intersection of infectious disease dynamics, health systems planning, and data-driven decision support, positioning her work within a globally relevant domain of applied epidemiology. Beyond academic metrics, her contributions have societal impact by informing approaches to epidemic preparedne  ss, guiding interventions for vulnerable demographic groups, and enhancing understanding of spatial disparities in health outcomes. Through her continued scholarship, Manjoo-Docrat aims to strengthen the integration of mathematical modelling into national and regional public health strategies, ensuring that data-informed insights contribute to improved health resilience and equitable disease control.

Profiles: Scopus | ORCID

Featured Publications

1. Manjoo-Docrat, R., Abdelatif, N., Holloway, J., Dudeni-Tlhone, N., Dresselhaus, C., Mbayise, E., … Makhanya, S. (2025). Spatial age-stratified epidemiological model with applications to South African COVID-19 pandemic. Heliyon, 11(11), e43171. https://doi.org/10.1016/j.heliyon.2025.e43171

2. Dresselhaus, C., Fabris-Rotelli, I., Manjoo-Docrat, R., Brettenny, W., Holloway, J., Thiede, R., Debba, P., & Dudeni-Tlhone, N. (2023). A spatial model with vaccinations for COVID-19 in South Africa. Spatial Statistics, 58, Article 100792. Cited by 2.

3. Manjoo-Docrat, R. (2022). A spatio-stochastic model for the spread of infectious diseases. Journal of Theoretical Biology, 533, 110943.  Cited by 16.

4. Fabris-Rotelli, I., Holloway, J., Kimmie, Z., Archibald, S., Debba, P., Manjoo-Docrat, R., … Potgieter, A. (2022). A Spatial SEIR Model for COVID-19 in South Africa. Journal of Data Science, Statistics, and Visualisation, 2(7), 14–45.  Cited by 5.

Amos Kipkorir Langat | Infectious Disease | Best Researcher Award

Assist. Prof. Dr. Amos Kipkorir Langat | Infectious Disease | Best Researcher Award 

Senior Research Fellow | Jomo Kenyatta University of Agriculture and Techno | Kenya

Dr. Amos Kipkorir Langat, Ph.D., is a highly accomplished statistician, academic, and economist with expertise in Bayesian analysis, machine learning, spatial statistics, and public health modeling. He earned his Ph.D. in Mathematics (Statistics) from the Pan African University Institute for Basic Sciences, Technology and Innovation, his MSc. in Applied Statistics from Jomo Kenyatta University of Agriculture and Technology (JKUAT), and his BSc. in Economics and Mathematics from Kabarak University. Currently, he serves as a Lecturer at JKUAT and Senior Economist at the County Government of Bomet, with previous teaching roles at Maasai Mara and Kabarak Universities. His research spans statistical modeling of infectious diseases, HIV risk factors, maternal health, survival and time series analysis, and measurement error models. He has supervised MSc. and Ph.D. students across Africa, authored over 30 peer-reviewed publications, and contributed to journals such as Scientific African, Asian Journal of Probability and Statistics, and Annals of Medicine & Surgery. Dr. Langat has secured prestigious awards including the AU Ph.D. Scholarship and SICSS research funding, and he actively contributes as a reviewer and conference organizer. His technical expertise includes proficiency in R, Python, STATA, SAS, SPSS, WinBUGS/OpenBUGS, and advanced econometric tools. A member of the Royal Statistical Society, ISCB, IBS, and the Kenya National Statistical Society, he also demonstrates a strong commitment to community service through educational leadership roles. Dr. Langat exemplifies a dedicated scholar, mentor, and researcher advancing applied statistics in public health and beyond

Profile: Google Scholar | Scopus | Orcid

Featured Publications

1. Langat, A., Orwa, G., & Koima, J. (2017). Cancer cases in Kenya; forecasting incidents using Box & Jenkins ARIMA model. Biomedical Statistics and Informatics, 2(2), 37–48. Cited by: 21

2. Benki-Nugent, S. F., Martopullo, I., Laboso, T., Tamasha, N., Wamalwa, D. C., … [and others]. (2019). High plasma soluble CD163 during infancy is a marker for neurocognitive outcomes in early-treated HIV-infected children. JAIDS Journal of Acquired Immune Deficiency Syndromes, 81(1), 102–109. Cited by: 14

3. Mutinda, J. K., & Langat, A. K. (2024). Stock price prediction using combined GARCH-AI models. Scientific African, 26, e02374. Cited by: 10

4. Mutinda, J. K., & Langat, A. K. (2024). Modeling the impact of air pollution and meteorological variables on COVID-19 transmission in Western Cape, South Africa. International Journal of Mathematics and Mathematical Sciences, 2024(1), 1591016. Cited by: 5

5. Mutinda, J. K., & Langat, A. K. (2024). Capital asset pricing model: A renewed application on S&P 500 index. Asian Journal of Economics, Business and Accounting, 24(6), 226–239. Cited by: 4

Marie Amougou Atsama | Gastroenteritis | Best Researcher Award

Dr. Marie Amougou Atsama | Gastroenteritis | Best Researcher Award 

Research Officer at Research Center on Emerging and Re-merging ,Cameroon

Dr. Amougou Atsama Marie is a highly accomplished public health manager and virologist with extensive expertise in research, biosafety, and disease prevention. She currently serves as Biosafety Officer and Public Health Manager at the Research Center for Emerging and Re-Emerging Infectious Diseases in Yaoundé, Cameroon. With a strong focus on viral hepatitis and other infectious diseases, she has led numerous initiatives aimed at prevention, surveillance, and control within Central Africa. Her work spans laboratory research, public health program coordination, and stakeholder engagement at national and regional levels. Dr. Marie has played a key role in developing diagnostic protocols, improving health systems, and fostering community-based prevention strategies. Her leadership extends to advocacy, capacity building, and integrating innovative approaches, such as the use of improved traditional medicine in disease management. Dedicated, results-oriented, and deeply committed to public health, she continues to advance impactful research and healthcare improvement in underserved communities.

Professional Profile

Scopus

Education

Dr. Amougou Atsama Marie possesses a strong academic background in virology, biotechnology, and biochemistry, built through rigorous studies and advanced research training. She completed her doctoral and postdoctoral work at the renowned Centre Pasteur of Cameroon, where she specialized in the molecular and epidemiological aspects of various viral pathogens. She earned her master’s degree in biotechnology and development from the University of Yaoundé I, developing a foundation in molecular biology, diagnostics, and public health applications. Her undergraduate degree in biochemistry further strengthened her understanding of biological systems and analytical methods. Over the years, she has complemented her formal education with specialized certifications in good clinical laboratory practice, human research ethics, quality control management, and advanced genomic sequencing techniques. These academic achievements, coupled with hands-on research experience, have equipped her with both theoretical knowledge and practical expertise, enabling her to design, implement, and oversee complex public health and laboratory research programs effectively.

Experience

Dr. Amougou Atsama Marie has established herself as a leader in public health management and virology through diverse roles in research, biosafety, and quality control. As Biosafety and Research Officer, she has coordinated regional efforts for the elimination of viral hepatitis B and C across multiple Central African countries, facilitating capacity-building workshops and advocacy programs. She has developed and optimized diagnostic protocols for a range of viruses, including hepatitis B, C, D, E, Dengue, Chikungunya, and Zika, while implementing robust surveillance and monitoring systems. Her work involves close collaboration with national and international health partners to strengthen healthcare delivery and integrate innovative solutions into disease prevention strategies. She has also led research on vaccine response, genetic diversity of hepatitis viruses, and the integration of traditional medicine in treatment. In addition to her technical expertise, she actively engages in community education, raising awareness about infectious disease prevention among students and the public.

Awards and Honors

Dr. Amougou Atsama Marie has received multiple recognitions for her outstanding contributions to virology research, biosafety, and public health initiatives. Her leadership in hepatitis elimination programs across Central Africa has earned her commendations from national health authorities and regional stakeholders. She has been honored for her innovative approaches in integrating traditional medicine into viral hepatitis management and for developing advanced diagnostic protocols for various infectious diseases. Her work in facilitating high-impact workshops, mentoring healthcare professionals, and contributing to national health guidelines has been acknowledged by both academic and public health institutions. She is respected for her role in promoting cross-border collaboration in disease control and for her dedication to building local capacity in laboratory diagnostics and biosafety management. Through these recognitions, Dr. Marie’s influence extends beyond research, highlighting her as a key figure in advancing evidence-based, community-centered health solutions in Cameroon and the broader Central African region.

Research Focus

Dr. Amougou Atsama Marie’s research centers on the prevention, diagnosis, and control of viral hepatitis and other emerging infectious diseases. She is particularly focused on understanding the genetic diversity of hepatitis viruses and its impact on vaccine response and treatment outcomes. Her work involves developing and optimizing molecular and serological diagnostic protocols for a wide range of viruses, including arboviruses such as Dengue, Chikungunya, and Zika. She also investigates strategies to integrate traditional medicine into viral hepatitis management, aiming to improve accessibility and cultural acceptance of treatment in local communities. Dr. Marie is actively involved in operational research that strengthens health systems, enhances biosafety measures, and improves outbreak preparedness. Her approach combines laboratory-based research with community engagement, ensuring that scientific advancements translate into practical, sustainable health solutions. By bridging research, policy, and public health action, she contributes to regional and global efforts to control infectious diseases effectively.

Publication Top Notes

Title: First molecular detection of five gastroenteritis viruses in untreated wastewater and impact of seasonal change on their distribution in Cameroon
Journal: One Health (2025)
Summary:
This study presents the first molecular evidence of five major gastroenteritis-causing viruses detected in untreated wastewater in Cameroon. Using molecular techniques, researchers identified the presence of these pathogens and assessed how their distribution varies across different seasons. The findings reveal a clear influence of seasonal patterns on virus prevalence, highlighting the importance of wastewater surveillance as an early warning system for community health risks. The research supports the One Health approach by linking environmental monitoring to public health interventions, offering valuable insights for disease prevention and control strategies in the region.

Conclusion

Dr. Amougou Atsama Marie embodies a rare combination of scientific expertise, leadership, and dedication to public health improvement. Her career reflects a consistent commitment to advancing research, enhancing diagnostic capabilities, and promoting evidence-based interventions for infectious disease control. Through her work in laboratory innovation, biosafety, and community engagement, she has significantly contributed to the fight against viral hepatitis and other infectious threats in Central Africa. Her ability to collaborate with diverse stakeholders, from policymakers to grassroots organizations, underscores her holistic approach to healthcare solutions. By integrating modern scientific methods with culturally sensitive strategies, she ensures that her work is both impactful and sustainable. Dr. Marie’s professional journey serves as an inspiring example of how research excellence and public health service can intersect to create lasting change, improving the lives of individuals and strengthening health systems across regions.